Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01927302 · ClinicalTrials.gov registry record · NA
Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01927302: Completed NA study, sponsored by Northwestern University.
NCT01927302 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01927302, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of treatment for specific language deficits in people with aphasia. In addition to language and cognitive measures, changes in brain function will also be gathered before and after the treatment is administered in order to track any changes resulting from receiving treatment.
Primary Outcome
Standard and non-standard measures of language and cognitive abilities will be gathered at baseline (week 0) to see if language deficits improve after treatment is administered (week 12).
Interventions
- BEHAVIORAL Treatment Focusing on Naming Objects
- BEHAVIORAL Treatment Focusing on Improving Spelling Abilities
- BEHAVIORAL Treatment Focusing on Improving Sentence Processing
- BEHAVIORAL No Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2013-04 |
| Est. Completion | 2019-03-27 |
| Phase | NA |
What the finished NCT01927302 record still lists
NCT01927302 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 4 interventions - of which Treatment Focusing on Naming Objects is the first listed.
NCT01927302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01927302 about?
NCT01927302 is a clinical study titled "Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery". The purpose of this study is to investigate the effects of treatment for specific language deficits in people with aphasia. In addition to language and cognitive measures, changes in brain function will also be gathered before and after the treatment is administered in order to track any changes res...
What is the current status of trial NCT01927302?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2013-04. Estimated completion is 2019-03-27.
What interventions are being tested in trial NCT01927302?
The interventions under investigation include: Treatment Focusing on Naming Objects (BEHAVIORAL), Treatment Focusing on Improving Spelling Abilities (BEHAVIORAL), Treatment Focusing on Improving Sentence Processing (BEHAVIORAL), No Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01927302?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01927302's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia